Our aforementioned results showed that FBXL2 is a key negative regulator of EGFR, we, therefore, investigated the effects of FBXL2 on cell proliferation and tumor growth using H292 cells, which express high levels of wild-type EGFR31. The gene discussed is EGFR; the disease is neoplasm.